StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a hold rating on the stock.
Brooklyn ImmunoTherapeutics Stock Down 4.6 %
Shares of NYSE:BTX opened at $1.04 on Tuesday. The stock has a market capitalization of $61.18 million, a PE ratio of -0.48 and a beta of 4.61. The firm’s 50 day moving average price is $1.30 and its 200-day moving average price is $1.69. Brooklyn ImmunoTherapeutics has a twelve month low of $0.17 and a twelve month high of $10.10.
Brooklyn ImmunoTherapeutics Company Profile
Featured Articles
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- What is the S&P 500 and How It is Distinct from Other Indexes
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Why is the Ex-Dividend Date Significant to Investors?
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.